Home › Funds › Portolan Capital Management, LLC › CDNA
Portolan Capital Management, LLC position in CDNA
CAREDX INC · Health Care
Portolan Capital Management, LLC reported holding 684,805 shares of CDNA (CAREDX INC) in its Q2 2026 13F filing — a position valued at US$19.5M, representing 0.73% of its reported portfolio and ranking #47 among its reported holdings. Portolan Capital Management, LLC has disclosed CDNA holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Portolan Capital Management, LLC's CDNA position evolved
Portolan Capital Management, LLC first disclosed a stake in CDNA in Q1 2025 at 411,683 shares (US$7.3M). The position peaked in Q2 2026 at 684,805 shares, worth US$19.5M. Across 6 filings, Portolan Capital Management, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 684,805 shares valued at US$19.5M — an increase of 344,453 shares quarter over quarter.. Notable position changes include a 53% increase in Q2 2025 (shares fell 26% over the following quarter), a 55% trim in Q1 2026 (shares rose 64% over the following quarter), a 101% increase in Q2 2026 (shares rose 128% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 411.68K | $7.31M | New |
| Q2 2025 | 629.98K | $12.31M | Add |
| Q3 2025 | 933.53K | $13.57M | Add |
| Q4 2025 | 758.77K | $14.30M | Reduce |
| Q1 2026 | 340.35K | $5.91M | Reduce |
| Q2 2026 | 684.80K | $19.52M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CDNA and 13F data
CDNA (CAREDX INC) is a Health Care company. 40 other funds we track also report a position in CDNA — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$56.9M), GAGNON SECURITIES LLC (US$50.5M), Ophir Asset Management Pty Ltd (US$36.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CDNA
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.00M sh · $56.93M · Q2 2026
- GAGNON SECURITIES LLC 1.77M sh · $50.47M · Q2 2026
- Ophir Asset Management Pty Ltd 1.26M sh · $36.05M · Q2 2026
- BRAIDWELL LP 1.22M sh · $34.79M · Q2 2026
- Blue Water Life Science Advisors, LP 1.19M sh · $33.91M · Q2 2026
- Divisadero Street Capital Management, LP 700.94K sh · $19.98M · Q2 2026
- Gagnon Advisors, LLC 546.89K sh · $15.59M · Q2 2026
- Palo Alto Investors LP 531.87K sh · $15.16M · Q2 2026
More on Portolan Capital Management, LLC
FAQ
How long has Portolan Capital Management, LLC held CDNA?
Portolan Capital Management, LLC has disclosed CDNA holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Portolan Capital Management, LLC's current position in CDNA?
As of Q2 2026, Portolan Capital Management, LLC holds 684.80K shares of CDNA (CAREDX INC), valued at $19.52M, representing 0.73% of its reported portfolio and ranking #47.
Has Portolan Capital Management, LLC been buying or selling CDNA?
In the latest 13F filing (Q2 2026), Portolan Capital Management, LLC increased its position in CDNA. The position peaked in Q2 2026 at 684.80K shares.
Which other funds hold CDNA?
Other major institutional holders of CDNA include DEERFIELD MANAGEMENT COMPANY, L.P., GAGNON SECURITIES LLC, Ophir Asset Management Pty Ltd, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.